Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies

Margolis, E., Brown, G., Partin, A., Carter, B., McKiernan, J., Tutrone, R., Torkler, P., Fischer, C., Tadigotla, V., Noerholm, M., Donovan, M. J., & Skog, J. (2021). Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies. Prostate Cancer and Prostatic Diseases, 25(2), 296–301. https://doi.org/10.1038/s41391-021-00456-8
Authors:
Erik Margolis
Gordon Brown
Alan Partin
Ballentine Carter
James McKiernan
Ronald Tutrone
Phillipp Torkler
Christian Fischer
Vasisht Tadigotla
Mikkel Noerholm
Michael J. Donovan
Johan Skog
Affiliated Authors:
James McKiernan
Publication Type:
Article
Unique ID:
10.1038/s41391-021-00456-8
PMID:
Publication Date:
Data Source:
Scopus

Record Created: